Yale Cancer Center NCTN
Yale Cancer Center NCTN
批准号:
8605651
负责人:
PETER M GLAZER
金额:
$55.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-16 至 2019-02-28
关键词:
Advanced Malignant NeoplasmAdvocateAllyAntimetabolitesCalendarCancer BiologyCancer CenterCancer HospitalCancer PatientCaringClinicalClinical OncologyClinical ResearchClinical TrialsClinical Trials Cooperative GroupClinical Trials NetworkComprehensive Cancer CenterCooperative Group ProgramDermatologyDisciplineDiseaseDoctor of MedicineEnsureFund RaisingFundingGeneral HospitalsGrantGynecologic OncologyHealthHematologyHospitalsInstitutesIntentionLaboratoriesLeadLeadershipMalignant NeoplasmsMassachusettsMedical OncologyMentorsMentorshipOperations ResearchOperative Surgical ProceduresPersonnel StaffingPharmacologyPhysiciansPositioning AttributePrincipal InvestigatorRadiation OncologyRecording of previous eventsRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResourcesSiteSupervisionSurgeonSystemTimeTrainingTranslational ResearchUnited StatesUniversitiesVisionWarWorkYale Cancer Centerbasecancer pharmacologycancer research center directorcancer therapycareerdrug developmentmedical schoolsmeetingsnext generationprogramsresponsestandard of care
中文摘要
描述(由申请者提供):此申请建议耶鲁大学成为新建立的NCI国家临床试验网络下的网络领先学术参与网站(LAPS)。作为一个大家庭,耶鲁大学将1.在耶鲁综合癌症中心(YCC)促进和倡导NCTN临床研究;2.继续扩大NCTN试验的收益,并向YCC成员提供这些重要国家试验的广泛机会;3.提供必要的科学领导,以推动NCI资助的NCTN系统研究事业,并领导将提高癌症治疗和护理标准的重要试验;4.为这些NCTN临床试验提供翻译科学和实验室支持;5.培训和指导NCTN小组的年轻研究人员,帮助他们提供下一代科学领导
英文摘要
DESCRIPTION (provided by applicant): This application proposes that Yale University become a Network Lead Academic Participating Site (LAPS) under the newly established NCI National Clinical Trials Network. As an LAPS Yale University will 1. Promote and advocate for NCTN clinical research at the Yale Comprehensive Cancer Center (YCC); 2.continue expanding accrual to NCTN trials and provide broad based access to these important national trials to YCC membership; 3. Provide the scientific leadership necessary in order to advance the cause of NCI funded research in the NCTN system and lead important trials that will advance cancer treatment and standard of care; 4. Provide the translational science and laboratory support for these NCTN clinical trials; 5. Train and mentor Young Investigators in the NCTN groups and help them to provide the next generation of scientific leadership
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PNA Nanoparticles for Gene Editing In Vivo
-
批准号:10198735
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2019
-
负责人:PETER M GLAZER
-
依托单位:
PNA Nanoparticles for Gene Editing In Vivo
-
批准号:9804726
-
项目类别:
-
资助金额:$42.11万
-
财政年份:2019
-
负责人:PETER M GLAZER
-
依托单位:
PNA Nanoparticles for Gene Editing In Vivo
-
批准号:10414795
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2019
-
负责人:PETER M GLAZER
-
依托单位:
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung
-
批准号:10274829
-
项目类别:
-
资助金额:$75.68万
-
财政年份:2018
-
负责人:PETER M GLAZER
-
依托单位:
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung
-
批准号:10706300
-
项目类别:
-
资助金额:$114.48万
-
财政年份:2018
-
负责人:PETER M GLAZER
-
依托单位:
Poly(amine-co-ester)s for targeted delivery of gene editing agents to treat cystic fibrosis in animal models: SCGE Disease Models Studies Supplement
-
批准号:10619840
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2018
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:9388067
-
项目类别:
-
资助金额:$77.33万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:10204894
-
项目类别:
-
资助金额:$100.49万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:10456727
-
项目类别:
-
资助金额:$98.49万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:9981673
-
项目类别:
-
资助金额:$100.49万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Yale Cancer Biology Training Grant
-
批准号:10170726
-
项目类别:
-
资助金额:$44.14万
-
财政年份:2016
-
负责人:PETER M GLAZER
-
依托单位:
Yale Cancer Biology Training Grant
-
批准号:10394345
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2016
-
负责人:PETER M GLAZER
-
依托单位:
Yale Cancer Biology Training Grant
-
批准号:10599891
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2016
-
负责人:PETER M GLAZER
-
依托单位:
Bifunctional Antibodies for Melanoma Therapy
-
批准号:8755327
-
项目类别:
-
资助金额:$45.94万
-
财政年份:2014
-
负责人:PETER M GLAZER
-
依托单位:
In vivo genomic editing of hematopoietic cells for HIV resistance
-
批准号:9110812
-
项目类别:
-
资助金额:$60.79万
-
财政年份:2014
-
负责人:PETER M GLAZER
-
依托单位:
Bifunctional Antibodies for Melanoma Therapy
-
批准号:8916650
-
项目类别:
-
资助金额:$44.27万
-
财政年份:2014
-
负责人:PETER M GLAZER
-
依托单位:
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy
-
批准号:8500076
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2013
-
负责人:PETER M GLAZER
-
依托单位:
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy
-
批准号:8826075
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:PETER M GLAZER
-
依托单位:
Novel triplex-engineered, BRCA1-mutated cell lines for research
-
批准号:8412753
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2012
-
负责人:PETER M GLAZER
-
依托单位:
Novel triplex-engineered, BRCA1-mutated cell lines for research
-
批准号:8239269
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2012
-
负责人:PETER M GLAZER
-
依托单位:
海外基金